Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 17.

Feng, Yi, Sanders, Andrew J., Morgan, Liam D., Owen, Sioned, Ruge, Fiona, Harding, Keith G and Jiang, Wen Guo 2017. In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing. Scientific Reports 7 (1) , 6715. 10.1038/s41598-017-06886-6
file

Feng, Yi, Sanders, Andrew, Morgan, Liam, Harding, Keith and Jiang, Wen 2016. Potential roles of suppressor of cytokine signaling in wound healing. Regenerative Medicine 11 (2) , pp. 193-209. 10.2217/rme.16.4

Hamilton, Emma, Pearce, Laurence, Morgan, Liam, Robinson, Sophie, Ware, Victoria Lesley, Brennan, Paul, Thomas, N. Shaun B., Yallop, Deborah, Devereux, Stephen, Fegan, Christopher D., Buggins, Andrea G. S. and Pepper, Christopher John 2012. Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells. British Journal of Haematology 158 (5) , pp. 589-599. 10.1111/j.1365-2141.2012.09191.x

Evans, Bronwen Alice James, Bullen, Melanie Jean, Kench, Rebecca Carol, Fox, Rebecca E., Morgan, Liam David, Stevenson, Amy Elizabeth, Gevers, Evelien F., Perry, Mark J. and Wells, Timothy 2011. The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats. Journal of Endocrinology 208 (1) , pp. 69-79. 10.1677/JOE-10-0178

Pepper, Christopher John, Mahdi, J. G., Buggins, A. G. S., Hewamana, Saman, Walsby, Elisabeth Jane, Mahdi, Eamon, Al-Haza'a, A., Mahdi, Ali J., Lin, Thet Thet, Pearce, Laurence, Morgan, Liam David, Bowen, Ivor D., Brennan, Paul and Fegan, Christopher Daniel 2011. Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation 44 (4) , pp. 380-390. 10.1111/j.1365-2184.2011.00760.x

Pearce, Laurence, Morgan, Liam David, Lin, Thet Thet, Hewamana, Saman, Matthews, Reginald James, Deaglio, Silvia, Rowntree, Clare, Fegan, Christopher Daniel, Pepper, Christopher John and Brennan, Paul 2010. Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38. Haematologica 95 (3) , pp. 514-517. 10.3324/haematol.2009.014381

Morgan, Liam David, Gee, Julia Margaret Wendy, Pumford, Sara Louise, Farrow, Lynne, Finlay, Pauline, Robertson, John, Ellis, Ian, Kawakatsu, Hisaaki, Nicholson, Robert Ian and Hiscox, Stephen Edward 2009. Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically. Cancer Biology and Therapy 8 (16) , pp. 1550-1558. 10.4161/cbt.8.16.8954

Hiscox, Stephen Edward, Jordan, Nicola Jane, Smith, Chris, James, M., Morgan, Liam David, Taylor, Kathryn Mary, Green, T. P. and Nicholson, Robert Ian 2009. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment 115 (1) , pp. 57-67. 10.1007/s10549-008-0058-6

Hiscox, Stephen Edward, Jordan, Nicola Jane, Morgan, Liam David, Smith, Christopher, Goddard, Lindy, Gee, Julia Margaret Wendy and Nicholson, Robert 2009. Adverse features of acquired antihormone resistance and their targeting. In: Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert eds. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets, London: Springer, pp. 139-160. (10.1007/978-1-4020-8526-0_8)

Morgan, Liam David, Nicholson, Robert and Hiscox, Stephen 2008. Src as a therapeutic target in breast cancer. Endocrine‚ Metabolic & Immune Disorders - Drug Targets 8 (4) , pp. 273-278. 10.2174/187153008786848295

Hiscox, Stephen Edward, Jordan, Nicola Jane, Morgan, Liam David, Green, T. P. and Nicholson, Robert Ian 2007. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clinical & Experimental Metastasis 24 (3) , pp. 157-167. 10.1007/s10585-007-9065-y

Morgan, Liam David 2007. Elevated Src kinase activity accompanies endocrine-resistance in breast cancer and promotes an aggressive cell phenotype. PhD Thesis, Cardiff University.
file

Hiscox, Stephen Edward, Morgan, Liam David, Green, Tim and Nicholson, Robert 2006. Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocrine-Related Cancer 13 , S53-S59. 10.1677/erc.1.01297

Hiscox, Stephen Edward, Morgan, Liam David, Green, Tim P., Barrow, Denise, Gee, Julia Margaret Wendy and Nicholson, Robert Ian 2006. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast cancer research and treatment 97 (3) , pp. 263-274. 10.1007/s10549-005-9120-9

Hiscox, Stephen Edward, Jiang, Wen Guo, Obermeier, Kathrin, Taylor, Kathryn Mary, Morgan, Liam David, Burmi, Rajpal Singh, Barrow, Denise and Nicholson, Robert Ian 2006. Tamoxifen-resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of [beta]-catenin phosphorylation. International journal of cancer 118 (2) , pp. 290-301. 10.1002/ijc.21355

Hiscox, Stephen Edward, Morgan, Liam David, Barrow, Denise, Dutkowski, Carol Mary, Wakeling, Alan and Nicholson, Robert Ian 2004. Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839). Clinical & Experimental Metastasis 21 (3) , pp. 201-212. 10.1023/B:CLIN.0000037697.76011.1d

Morton, Michael S., Arisaka, Osamu, Miyake, Noriko, Morgan, Liam David and Evans, Bronwen Alice James 2002. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. Journal of Nutrition 132 (10) , pp. 3168-3171.

This list was generated on Wed Jun 19 03:52:27 2019 BST.